the Horsens Aarhus FemoroAcetabular Impingement Syndrome Training Pilot Study
NCT ID: NCT05031390
Last Updated: 2025-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2021-09-01
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Arthroscopic Treatment of Patients in Horsens and Aarhus With FemoroAcetabular Impingement: the HAFAI-cohort
NCT02306525
First-line Treatment for Femoroacetabular Impingement Syndrome
NCT05927935
Diagnosis and Treatment of Patients With Femoroacetabular Impingement Syndrome
NCT03846817
HAFAI Cohort 5 Year Follow up of Patients With Femoroacetabular Impingement Undergoing Hip Arthroscopy
NCT04590924
Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery
NCT04243447
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physiotherapist-led training
Physiotherapy-led training of patients with FAIS
Physiotherapist-led training
Patients will undergo a 12-week physiotherapist-led training program consisting of 8 supervised sessions and home-based training in between
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physiotherapist-led training
Patients will undergo a 12-week physiotherapist-led training program consisting of 8 supervised sessions and home-based training in between
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diagnosed with FAIS according to the Warwick agreement
3. Patients having cam morphology should have an alpha angle of \> 55 degrees on an anterior-posterior radiograph.
4. Patients having pincer should have a lateral centre edge angle of \>39 degrees on an anterior-posterior radiograph.
5. Lateral joint space width should be \>3 mm.
6. Body mass index is below 30.
7. Motivated for participation in a 12 week training program with 8 physical attendances.
Exclusion Criteria
2. Previous hip surgery in included hip or other major hip injury,
3. Systemic conditions e.g. rheumatoid arthritis, cancer,
4. Chronical pain syndromes,
5. Unable to perform testing procedures,
6. Unable to attend a 12-week treatment program or baseline and follow-up assessments
7. Contraindications to radiographs (e.g. pregnancy)
8. Unable to read or understand questionnaires and/or instructions
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
La Trobe University
OTHER
Horsens Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeppe Lange
Head of Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Signe Kierkegaard, PhD
Role: PRINCIPAL_INVESTIGATOR
Regionshospitalet Horsens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Signe Kierkegaard
Horsens, Danmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-16-02-724-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.